Gland Pharma Limited (NSE: GLAND) Q3 2026 Earnings Call dated Jan. 28, 2026 Corporate Participants: Shriniwas P Dange — Head of Investor Relations Srinivas Sadu — Executive Chairman Shyamakant Giri — Chief Executive Officer Ravi Mitra — Chief Financial Officer – India Office Alain Kirchmeyer — Chief Executive Officer – Cenexi Analysts: Tushar Manudhane — […]
Executive Summary Gland Pharma Ltd reported Q3FY26 revenues of ₹1,695 crore, up 22.47% YoY, with consolidated net profit rising 27.32% to ₹261 crore. Total expenses increased 20.03% YoY to ₹1,372 crore, reflecting strong revenue growth with controlled cost escalation. Revenue & Growth Revenues grew to ₹1,695.00 crore in Q3FY26 from ₹1,384.00 crore YoY, marking 22.47% […]
Piramal Pharma Ltd (NSE: PPLPHARMA), a leading global pharmaceutical and life sciences company headquartered in Mumbai, reported its financial results for the third quarter (Q3) of the fiscal year ending December 31, 2025, on January 29, 2026. The quarter’s performance reflects a mix of operational challenges alongside areas of resilient execution, underscoring the cyclical nature […]
Gland Pharma Limited (NSE: GLAND) shares were trading around ₹1,688, up about 0.8% in early Wednesday deals, after the Hyderabad-based injectables maker reported its third-quarter results. The stock trades well below its 52-week high of ₹2,131 and above its 52-week low near ₹1,278, reflecting a sideways to slightly softer trend over the past year. Quarterly […]
Jagsonpal Pharmaceuticals Ltd (NSE: JAGSNPHARM) Q3 2026 Earnings Call dated Jan. 22, 2026 Corporate Participants: Manish Gupta — Managing Director Amrut Medhekar — Chief Operating Officer Nirav Vora — Chief Financial Officer Analysts: Soumya Chhajed — Analyst Deepesh J Sancheti — Analyst Neelam Punjabi — Analyst Aditya Chheda — Analyst Sajal Kapoor — Analyst Pulavarthi […]
Onesource Specialty Pharma Ltd (NSE: ONESOURCE) Q3 2026 Earnings Call dated Jan. 24, 2026 Corporate Participants: Arun Kumar — Founder and Non-Executive Director Neeraj Sharma — Chief Executive Officer and Managing Director Anurag Bhagania — Chief Financial Officer Abhishek Singhal — Company Secretary Analysts: Unidentified Participant Abdulkader Puranwala — Analyst Rupesh Tatia — Analyst Nitin […]
OneSource Specialty Pharma Ltd (BSE: 544292 / NSE: ONESOURCE) has emerged as a multi-modality contract development and manufacturing organisation (CDMO) following the integration of biologics, drug-device combinations, sterile injectables, and oral technologies businesses. While near-term financial performance in Q3 FY26 was affected by regulatory approval delays and revenue deferrals, disclosures indicate continued expansion in capacity, […]
OneSource Specialty Pharma Ltd (BSE: 544292 / NSE: ONESOURCE) reported consolidated revenue of ₹2.9 billion for the quarter ended December 31, 2025, a decline of 26% year-on-year, according to its Q3 FY26 earnings release. EBITDA stood at ₹173 million, down 88% from the corresponding quarter last year, while adjusted profit after tax was a loss […]
JB Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM) Q3 2026 Earnings Call dated Jan. 19, 2026 Corporate Participants: Unidentified Speaker Jason D’souza — Executive Vice President Nikhil Chopra — Chief Executive Officer & Whole Time Director Narayan Saraf — J.B. Chemicals & Pharmaceuticals Limited Elara Capital Analysts: Sumit Gupta — Analyst Pareen Parikh — Analyst Ananya […]
Alembic Pharmaceuticals Limited (NSE: APLLTD) Q2 2025 Earnings Call dated Nov. 07, 2024 Corporate Participants: Pranav Amin — Managing Director Raj Kumar Baheti — Director, Finance and Chief Financial Officer Ajay Kumar Desai — Senior Vice President, Finance Analysts: Rashmi Sancheti Shetty — Analyst Damayanti Kerai — Analyst Abdulkader Puranwala — Analyst Tushar Manudhane — […]